Biology Reference
In-Depth Information
4. Rubin CS, Rosen OM. Protein phosphorylation.
Annu Rev Biochem
1975;
44
:831-87.
5. Krebs EG, Beavo JA. Phosphorylation-dephosphorylation of enzymes.
Annu Rev Bio-
chem
1979;
48
:923-59.
6. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphory-
lation and signaling.
Cell
1995;
80
:225-36.
7. Cohen P. The origins of protein phosphorylation.
Nat Cell Biol
2002;
4
:E127-E130.
8. Hunter T. Protein kinase classification.
Methods Enzymol
1991;
200
:3-37.
9. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase
complement of the human genome.
Science
2002;
298
:1912-34.
10. Hunter T. A thousand and one protein kinases.
Cell
1987;
50
:823-9.
11. Maller JL. On the importance of protein phosphorylation in cell cycle control.
Mol Cell
Biochem
1993;
127
-
128
:267-81.
12. Johnson LN, Barford D. The effects of phosphorylation on the structure and function of
proteins.
Annu Rev Biophys Biomol Struct
1993;
22
:199-232.
13. Taylor SS, Radzio-Andzelm E. Three protein kinase structures define a common mo-
tif.
Structure
1994;
2
:345-55.
14. V´ron M, Radzio-Andzelm E, Tsigelny I, Taylor SS. Protein kinases share a common
structural motif outside the conserved catalytic domain.
Cell Mol Biol
1994;
40
:587-96.
15. Johnson LN, Noble ME, Owen DJ. Active and inactive protein kinases: structural basis
for regulation.
Cell
1996;
85
:149-58.
16. Huse M, Kuriyan J. The conformational plasticity of protein kinases.
Cell
2002;
109
:
275-82.
17. Ubersax JA, Ferrell Jr. JE. Mechanisms of specificity in protein phosphorylation.
Nat
Rev Mol Cell Biol
2007;
8
:530-41.
18. Turk BE. Understanding and exploiting substrate recognition by protein kinases.
Curr
Opin Chem Biol
2008;
12
:4-10.
19. Nolen B, Taylor S, Ghosh G. Regulation of protein kinases: controlling activity
through activation segment conformation.
Mol Cell
2004;
15
:661-75.
20. Brognard J, Hunter T. Protein kinase signaling networks in cancer.
Curr Opin Genet
Dev
2011;
21
:4-11.
21. Kumar R, Singh VP, Baker KM. Kinase inhibitors for cardiovascular disease.
J Mol Cell
Cardiol
2007;
42
:1-11.
22. Blease K. Targeting kinases in asthma.
Expert Opin Investig Drugs
2005;
14
:1213-20.
23. Ben-Bassat H. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis
therapy.
Curr Opin Investig Drugs
2001;
2
:1539-45.
24. Cohen P. Protein kinases—the major drug targets of the twenty-first century?
Nat Rev
Drug Discov
2002;
1
:309-15.
25. Manning BD. Challenges and opportunities in defining the essential cancer kinome.
Sci
Signal
2009;
2
:pe15.
26. Johnson L. Protein kinases and their therapeutic exploitation.
Biochem Soc Trans
2007;
35
:7-11.
27. Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer.
Nat Rev
Drug Discov
2009;
8
:547-66.
28. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a
selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.
Nat Med
1996;
2
:561-6.
29. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN,
van Deventer SJ, et al. A new phosphospecific cell-based ELISA for p42/p44
mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and
cAMP-response-element-binding protein.
Biochem J
2000;
350
(Pt 3):717-22.
30. Kupcho K, Somberg R, Bulleit B, Goueli SA. A homogeneous, nonradioactive high-
throughput fluorogenic protein kinase assay.
Anal Biochem
2003;
317
:210-7.
Search WWH ::
Custom Search